See All Slides -

Slides

Presentation TCT 2016

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: Vulnerable Plaque Is the Single Most Important Factor!

Presenter: Ran Kornowski, Michel R. Le May, Tej Sheth

October 31, 2016

Presentation TCT 2016

Early Insights From the DELTA-2 Registry

Presenter: Seung-Jung Park, Leif Thuesen, Alaide Chieffo

October 31, 2016

Presentation TCT 2016

Clinical Risk Assessment and Health Status Goals in the CHIP Population

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Adam C. Salisbury

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO

Presenter: Simon R. Dixon, Holger Thiele, A. Reshad Garan

October 31, 2016

Presentation TCT 2016

The Alphabet Soup of SFA Scaffolds and Their Outcomes: BMS, VMI, DES, PTFE

Presenter: Tony Das, Koen Deloose, Ehrin J. Armstrong

October 31, 2016

Presentation TCT 2016

Intervention for Venous Disease

Presenter: Raghu Kolluri, Vishal Kapur

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty III: Guided Delivery Systems Results, Device Iterations, and Future Directions

Presenter: Ted Feldman, Scott Lim, Horst Sievert

October 31, 2016

Presentation TCT 2016

Failure Modes of Bioresorbable Scaffolds: From the Obvious (Strut Thickness Considerations) to the Novel (Intraluminal Scaffold Dismantling)

Presenter: Elazer R. Edelman, Juan F. Granada

October 31, 2016

Presentation TCT 2016

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Presenter: Sunil V. Rao, Harvey D. White, Salvatore Brugaletta

October 31, 2016

Presentation TCT 2016

What Have We Learned From Contemporary Left Main Observational Studies IV? FLORENCE-LM Registry

Presenter: Seung-Jung Park, Leif Thuesen, David Antoniucci (RETIRED)

October 31, 2016

Advertisement

Slides

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: Vulnerable Plaque Is the Single Most Important Factor!

Early Insights From the DELTA-2 Registry

Clinical Risk Assessment and Health Status Goals in the CHIP Population

Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO

The Alphabet Soup of SFA Scaffolds and Their Outcomes: BMS, VMI, DES, PTFE

Intervention for Venous Disease

Direct Annuloplasty III: Guided Delivery Systems Results, Device Iterations, and Future Directions

Failure Modes of Bioresorbable Scaffolds: From the Obvious (Strut Thickness Considerations) to the Novel (Intraluminal Scaffold Dismantling)

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

What Have We Learned From Contemporary Left Main Observational Studies IV? FLORENCE-LM Registry

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content